Send a text

In this episode, we’re joined by Dr. Eugene Manley, founder of the STEM & Cancer Health Equity Foundation, for a powerful conversation about representation, health equity, and the structural barriers that continue to shape cancer outcomes.

Drawing from his experience growing up in inner-city Detroit and navigating academia as a first-generation scholar, Dr. Manley shares why he launched the foundation — and how it works to address disparities in lung cancer diagnosis, clinical trial access, and STEM participation.

We explore:

· Why lung cancer outcomes differ across communities

· How implicit bias shows up in clinical decision-making

· The importance of biomarker testing and clinical trial inclusion

· The role of mentorship pipelines in diversifying STEM

· How AI in healthcare can either reduce or amplify inequity

· Why representation in research and clinical teams matters

This episode is a candid and thought-provoking look at what health equity looks like in practice — not just in principle — and why intentional action is essential to create lasting change.

If you’re interested in public health, medical research, social justice in healthcare, or the future of equitable innovation, this conversation is not to be missed.

Find out more about Dr. Eugene Manley and his work at the STEM & Cancer Health Equity Foundation here: https://scheq.org/

Support the show